TRINITY BIOTECH PLC-SPON ADR

TRIB is the ticker symbol for Trinity Biotech plc, an Irish-American company focused on the development and manufacture of diagnostic products for the clinical laboratory and point-of-care markets. The stock represents an ownership stake in this publicly traded diagnostics firm. Shares are listed on the Nasdaq Capital Market under the symbol TRIB, giving investors exposure to the in-vitro diagnostics industry.

The latest price for TRIB is displayed at the top of this stock detail page and updates during regular market hours. Because share prices change continuously with trading activity, any figure quoted here could be stale. For the most accurate, real-time quote, including bid/ask and volume, refer to the live price data shown on this page or a licensed market data provider.

Trinity Biotech's share price has historically experienced significant volatility, influenced by factors such as quarterly earnings, clinical trial updates, regulatory decisions, and broader market sentiment toward small-cap healthcare stocks. Volatility can create larger price swings than those seen in more established large-cap companies. A review of the stock's historical price chart and 52-week range can provide context for its typical trading fluctuations.

Valuation for Trinity Biotech can be assessed using metrics such as price-to-sales, price-to-book, and enterprise value relative to revenue or EBITDA, since the company may not have consistent positive earnings. Comparing these ratios to peers in the diagnostics sector and reviewing historical valuation ranges can add context. Current valuation figures for TRIB are available through the financial data displayed on this page.

To buy TRIB shares, you need a brokerage account that offers access to Nasdaq-listed securities. Once funded, search for the ticker TRIB, place a buy order specifying the number of shares and order type (market or limit), and confirm the trade. Fractional shares may be available through some brokers. TRIB trades during regular U.S. market hours, and some brokers also offer extended-hours trading.

Key risks for Trinity Biotech include dependence on a limited number of diagnostic products, regulatory and reimbursement pressures in healthcare, foreign exchange exposure due to international operations, and the potential need for additional capital. The company has faced profitability challenges in the past, and its small-cap status can amplify share price swings. Reviewing SEC filings and the latest financial statements can help investors assess these risks.